| scholarly article | Q13442814 |
| P2093 | author name string | Diego F Calvisi | |
| Francesco Feo | |||
| Rosa M Pascale | |||
| Claudio F Feo | |||
| P2860 | cites work | Protein arginine methyltransferase 5 functions in opposite ways in the cytoplasm and nucleus of prostate cancer cells | Q24298151 |
| The carbohydrate metabolism of certain pathological overgrowths | Q24534388 | ||
| On the Occasion of World Cancer Day 2015; the Possibility of Cancer Prevention or Treatment with Antioxidants: The Ongoing Cancer Prevention Researches | Q26773628 | ||
| S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility | Q26829356 | ||
| Glutathione synthesis | Q26864265 | ||
| Hepatitis C Virus-Linked Mitochondrial Dysfunction Promotes Hypoxia-Inducible Factor 1 -Mediated Glycolytic Adaptation | Q27490543 | ||
| The crystal structure of tetrameric methionine adenosyltransferase from rat liver reveals the methionine-binding site | Q27625096 | ||
| Structure and function study of the complex that synthesizesS-adenosylmethionine | Q27684874 | ||
| Modulation of the p53/MDM2 interplay by HAUSP inhibitors | Q28075457 | ||
| A review of methionine dependency and the role of methionine restriction in cancer growth control and life-span extension | Q28260104 | ||
| Homocysteine and cardiovascular disease | Q28265188 | ||
| Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells | Q28270014 | ||
| Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated kinase-mediated control of growth in human hepatocellular carcinoma | Q28282387 | ||
| Regulation of cancer cell metabolism | Q28303890 | ||
| The intracellular localization of APE1/Ref-1: more than a passive phenomenon? | Q28307041 | ||
| Protein arginine methyltransferase 5 regulates ERK1/2 signal transduction amplitude and cell fate through CRAF | Q28567709 | ||
| HuR/methyl-HuR and AUF1 regulate the MAT expressed during liver proliferation, differentiation, and carcinogenesis | Q28568261 | ||
| An expression signature of phenotypic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis. | Q54318224 | ||
| Uptake and metabolism of S-adenosyl-L-methionine by isolated rat hepatocytes | Q67435302 | ||
| S-adenosylmethionine treatment prevents carbon tetrachloride-induced S-adenosylmethionine synthetase inactivation and attenuates liver injury | Q67555817 | ||
| Effect of the variations of S-adenosyl-L-methionine liver content on fat accumulation and ethanol metabolism in ethanol-intoxicated rats | Q69991963 | ||
| Role of phosphatidylethanolamine methylation in the synthesis of phosphatidylcholine by hepatocytes isolated from choline-deficient rats | Q70479021 | ||
| Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis | Q70646154 | ||
| Chiral instability at sulfur of S-adenosylmethionine | Q71787135 | ||
| Alterations of ornithine decarboxylase gene during the progression of rat liver carcinogenesis | Q72082452 | ||
| Effect of S-adenosyl-L-methionine on the development of preneoplastic foci and the activity of some carbohydrate metabolizing enzymes in the liver, during experimental hepatocarcinogenesis | Q72747514 | ||
| Ubiquitin Conjugating Enzyme Ubc9 is Involved in Protein Degradation of Redox Factor-1 (Ref-1) | Q74445569 | ||
| THE EFFECT OF 2-DESOXYGLUCOSE ON ENERGY METABOLISM AND PROTEIN SYNTHESIS OF TUMOR CELLS AND NORMAL CELLS | Q76834138 | ||
| Spectroscopic evidence of metabolic control | Q78573708 | ||
| S-adenosylmethionine regulates cytoplasmic HuR via AMP-activated kinase | Q79871806 | ||
| Role of lncRNAs as prognostic markers of hepatic cancer and potential therapeutic targeting by S-adenosylmethionine via inhibiting PI3K/Akt signaling pathways | Q88634776 | ||
| Methionine adenosyltransferases in liver health and diseases | Q89389038 | ||
| Inhibition of promotion and persistent nodule growth by S-adenosyl-L-methionine in rat liver carcinogenesis: role of remodeling and apoptosis. | Q53516048 | ||
| Altered methionine metabolism and global DNA methylation in liver cancer: relationship with genomic instability and prognosis. | Q53536112 | ||
| Conformational signals in the C-terminal domain of methionine adenosyltransferase I/III determine its nucleocytoplasmic distribution | Q28569026 | ||
| Role of HSP90, CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer | Q28574652 | ||
| Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC | Q28580086 | ||
| On respiratory impairment in cancer cells | Q29617276 | ||
| Cystathionine gamma-Lyase-deficient mice require dietary cysteine to protect against acute lethal myopathy and oxidative injury. | Q30496159 | ||
| Regulation of protein kinase cascades by protein phosphatase 2A. | Q33632946 | ||
| Forced expression of methionine adenosyltransferase 1A in human hepatoma cells suppresses in vivo tumorigenicity in mice | Q33816446 | ||
| Two essential but distinct functions of the mammalian abasic endonuclease | Q33936936 | ||
| S-adenosylmethionine regulates dual-specificity mitogen-activated protein kinase phosphatase expression in mouse and human hepatocytes. | Q34001374 | ||
| Redox and addition chemistry of quinoid compounds and its biological implications | Q34046274 | ||
| Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points | Q34283918 | ||
| S-adenosylmethionine inhibits the growth of cancer cells by reversing the hypomethylation status of c-myc and H-ras in human gastric cancer and colon cancer | Q34394796 | ||
| HIV-1 Vpr modulates macrophage metabolic pathways: a SILAC-based quantitative analysis | Q34848256 | ||
| Functional proteomics of nonalcoholic steatohepatitis: mitochondrial proteins as targets of S-adenosylmethionine | Q34866170 | ||
| Importance of a deficiency in S-adenosyl-L-methionine synthesis in the pathogenesis of liver injury | Q34990128 | ||
| S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease. | Q35108120 | ||
| Abasic sites in DNA: repair and biological consequences in Saccharomyces cerevisiae | Q35617303 | ||
| Effects of S-adenosylmethionine and methylthioadenosine on inflammation-induced colon cancer in mice | Q35755629 | ||
| Aerobic glycolysis tunes YAP/TAZ transcriptional activity | Q35819661 | ||
| Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation | Q35885731 | ||
| Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis | Q36077721 | ||
| AMPK promotes p53 acetylation via phosphorylation and inactivation of SIRT1 in liver cancer cells. | Q36207311 | ||
| Hepatocellular carcinoma as a complex polygenic disease. Interpretive analysis of recent developments on genetic predisposition | Q36282452 | ||
| Endogenous carbon monoxide downregulates hepatic cystathionine-γ-lyase in rats with liver cirrhosis | Q36334676 | ||
| MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma | Q36497209 | ||
| Expression pattern, regulation, and functions of methionine adenosyltransferase 2beta splicing variants in hepatoma cells | Q36692913 | ||
| S-adenosylmethionine regulates apurinic/apyrimidinic endonuclease 1 stability: implication in hepatocarcinogenesis | Q36694479 | ||
| Role of S-adenosyl-L-methionine in liver health and injury | Q36804166 | ||
| S-Adenosylmethionine in cell growth, apoptosis and liver cancer | Q37108891 | ||
| Role of methionine adenosyltransferase genes in hepatocarcinogenesis | Q37132635 | ||
| Protein phosphatase 2A regulatory subunits and cancer. | Q37202956 | ||
| LKB1; linking cell structure and tumor suppression | Q37333592 | ||
| Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease. | Q37580201 | ||
| Prognostic markers and putative therapeutic targets for hepatocellular carcinoma | Q37696630 | ||
| Metabolic aspects of epigenome: coupling of S-adenosylmethionine synthesis and gene regulation on chromatin by SAMIT module | Q38059656 | ||
| S-adenosylmethionine metabolism and liver disease. | Q38080431 | ||
| Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis | Q38105832 | ||
| Methionine adenosyltransferase α2 sumoylation positively regulate Bcl-2 expression in human colon and liver cancer cells | Q38262063 | ||
| Dysregulated glycolysis as an oncogenic event | Q38327525 | ||
| Prohibitin 1 suppresses liver cancer tumorigenesis in mice and human hepatocellular and cholangiocarcinoma cells | Q38725977 | ||
| Methionine adenosyltransferase 2B-GIT1 complex serves as a scaffold to regulate Ras/Raf/MEK1/2 activity in human liver and colon cancer cells | Q38897008 | ||
| A DNA methylation signature associated with the epigenetic repression of glycine N-methyltransferase in human hepatocellular carcinoma | Q39182952 | ||
| The TNF-α/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis | Q39308380 | ||
| Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G1 cyclins/cyclin-dependent kinases and the phosphoinositide 3-kinase/AKT signaling cascade | Q39326599 | ||
| S-adenosyl methionine regulates ubiquitin-conjugating enzyme 9 protein expression and sumoylation in murine liver and human cancers | Q39381663 | ||
| Hypoxia induces genomic DNA demethylation through the activation of HIF-1α and transcriptional upregulation of MAT2A in hepatoma cells | Q39565531 | ||
| Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype | Q39573753 | ||
| Methionine adenosyltransferase II serves as a transcriptional corepressor of Maf oncoprotein | Q39583808 | ||
| Activation of LKB1-Akt pathway independent of phosphoinositide 3-kinase plays a critical role in the proliferation of hepatocellular carcinoma from nonalcoholic steatohepatitis | Q39659924 | ||
| Changes in the expression of methionine adenosyltransferase genes and S-adenosylmethionine homeostasis during hepatic stellate cell activation | Q39756951 | ||
| S-adenosylmethionine in the chemoprevention and treatment of hepatocellular carcinoma in a rat model | Q39851067 | ||
| Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease. | Q39968256 | ||
| S-Adenosylmethionine and betaine correct hepatitis C virus induced inhibition of interferon signaling in vitro | Q40300400 | ||
| Methionine synthase activity and sulphur amino acid levels in the rat liver tumour cells HTC and Phi-1. | Q40749878 | ||
| The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes | Q40847581 | ||
| Effects of Antioxidant Supplements on the Survival and Differentiation of Stem Cells | Q41099472 | ||
| Identification of nitric oxide as an endogenous activator of the AMP-activated protein kinase in vascular endothelial cells | Q41901421 | ||
| Transmethylation, transsulfuration, and aminopropylation reactions of S-adenosyl-L-methionine in vivo | Q42243760 | ||
| Chemoprevention by S-adenosyl-L-methionine of rat liver carcinogenesis initiated by 1,2-dimethylhydrazine and promoted by orotic acid | Q42489252 | ||
| TNFalpha-dependent hepatic steatosis and liver degeneration caused by mutation of zebrafish S-adenosylhomocysteine hydrolase | Q43123082 | ||
| Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis | Q43411713 | ||
| 5'-Methylthioadenosine administration prevents lipid peroxidation and fibrogenesis induced in rat liver by carbon-tetrachloride intoxication. | Q43588115 | ||
| Variations of ornithine decarboxylase activity and S-adenosyl-L-methionine and 5'-methylthioadenosine contents during the development of diethylnitrosamine-induced liver hyperplastic nodules and hepatocellular carcinoma | Q43748218 | ||
| Inhibition by ethanol of rat liver plasma membrane (Na+,K+)ATPase: protective effect of S-adenosyl-L-methionine, L-methionine, and N-acetylcysteine | Q44630979 | ||
| Application of comparative functional genomics to identify best-fit mouse models to study human cancer | Q45163567 | ||
| The Glycolytic Switch in Tumors: How Many Players Are Involved? | Q45419184 | ||
| Differential expression of methionine adenosyltransferase genes influences the rate of growth of human hepatocellular carcinoma cells. | Q45958615 | ||
| Changes in S-adenosylmethionine synthetase in human liver cancer: molecular characterization and significance | Q46135216 | ||
| The differential NF-kB modulation by S-adenosyl-L-methionine, N-acetylcysteine and quercetin on the promotion stage of chemical hepatocarcinogenesis | Q46650717 | ||
| Early stimulation of polyamine biosynthesis during promotion by phenobarbital of diethylnitrosamine-induced rat liver carcinogenesis. The effects of variations of the S-adenosyl-L-methionine cellular pool | Q46929545 | ||
| Regulation of the human MAT2B gene encoding the regulatory beta subunit of methionine adenosyltransferase, MAT II. | Q48366524 | ||
| CHIP/Stub1 regulates the Warburg effect by promoting degradation of PKM2 in ovarian carcinoma. | Q50668089 | ||
| Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression. | Q53186782 | ||
| Persistent chemopreventive effect of S-adenosyl-L-methionine on the development of liver putative preneoplastic lesions induced by thiobenzamide in diethylnitrosamine-initiated rats. | Q53453110 | ||
| Ras-driven proliferation and apoptosis signaling during rat liver carcinogenesis is under genetic control. | Q53460647 | ||
| Specific induction of uncoiling and recombination by azacytidine in classical satellite-containing constitutive heterochromatin | Q53485244 | ||
| Comparative effects of L-methionine, S-adenosyl-L-methionine and 5'-methylthioadenosine on the growth of preneoplastic lesions and DNA methylation in rat liver during the early stages of hepatocarcinogenesis. | Q53497784 | ||
| Reversal by 5-azacytidine of the S-adenosyl-l-methionine-induced inhibition of the development of putative preneoplastic foci in rat liver carcinogenesis | Q53500275 | ||
| Protooncogene methylation and expression in regenerating liver and preneoplastic liver nodules induced in the rat by diethylnitrosamine: effect of variations of S-adenosylmethionine:S-adenosylhomocysteine ratio. | Q53514766 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 36 | |
| P577 | publication date | 2018-01-01 | |
| P1476 | title | Deregulation of methionine metabolism as determinant of progression and prognosis of hepatocellular carcinoma | |
| P478 | volume | 3 |
| Q92650058 | Deciphering the Link Between Hyperhomocysteinemia and Ceramide Metabolism in Alzheimer-Type Neurodegeneration |
| Q90271705 | Diminished S-adenosylmethionine biosynthesis and its metabolism in a model of hepatocellular carcinoma is recuperated by an adenosine derivative |
| Q98280937 | HNF4α regulates sulfur amino acid metabolism and confers sensitivity to methionine restriction in liver cancer |
| Q91689970 | Integration of metabolomics and expression of enolase-phosphatase 1 links to hepatocellular carcinoma progression |
| Q104064325 | Methionine metabolism in chronic liver diseases: an update on molecular mechanism and therapeutic implication |
| Q91981044 | The Role of AMP-Activated Protein Kinase as a Potential Target of Treatment of Hepatocellular Carcinoma |
Search more.